Corvidia Therapeutics is Biotechnology in United States that focus on next-generation precision business. Founded in 2015. They cover business area such as developer, next-generation precision cardiovascular therapy, intersection, patient, a unique sensitivity, specific biologic pathway, development, commercialization, transformative therapy, cardio-renal disease, medical provider, those pathway.
2015
( 9 years old in 2024 )
Next-generation Precision
-
35 Gatehouse Drive
Waltham, MA 02451
United States
Private
developernext-generation precision cardiovascular therapyintersectionpatienta unique sensitivityspecific biologic pathwaydevelopmentcommercializationtransformative therapycardio-renal diseasemedical providerthose pathway
* We use standard office opening hours in near Corvidia Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Corvidia Therapeutics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Corvidia Therapeutics business is focusing on Next-generation Precision.
Corvidia Therapeutics headquarter office and corporate office address is located in 35 Gatehouse Drive Waltham, MA 02451 United States.
Corvidia Therapeutics was founded in United States.
In 2024, Corvidia Therapeutics is currently focus on next-generation precision sector.
Above is snippet of Google Trends for "next-generation precision" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Corvidia Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
